Worldwide Sleep Apnea Device Market Trends and Drivers, Restraints, and Opportunities 2017-2023
Global Sleep Apnea Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Sleep apnea is a condition in which a person stops breathing for few seconds at night either due to airway blockage or because signal from the brain is not received. In severe conditions, a person stops breathing for more than 10 times in an hour. The American Journal of Epidemiology stated that in 2013, around 26% of the adults aged 30–70 years had some form of sleep apnea, whereby 16% of them had mild sleep apnea and 10% had severe sleep apnea.
Among the various forms of sleep apnea, obstructive sleep apnea (OSA) is the most common type. According to the WHO around 100 million people worldwide have OSA. In the US, OSA is said to affect 1 in 4 men and 1 in 9 women, which totals to 23 million working adults. Center for Disease Control and Prevention has also found that the annual healthcare cost for OSA in the US is $165 billion, which is higher than asthma and obesity. Sleep apnea is resulting in reduced productivity at work and increase in road accidents. The National Highway Traffic Safety Administration has estimated that around 100,000 car accidents, 40,000 injuries, and 1,550 deaths per year are caused due to driver’s fatigue.
The Global Sleep Apnea Devices Market is growing due to factors such as the rising usage of oral appliances, growing awareness of ill effects of untreated sleep apnea in developed countries, technological advances in diagnostics and therapeutic devices, and the increasing number of lifestyle diseases such as diabetes and obesity. However, alternative treatment for sleep apnea, lack of patient compliance, and stringent regulatory approval are some of the factors hampering the market. The market in India, Brazil, and China are also expected to grow at an accelerated pace during the forecast period.
Market Analysis: The Global Sleep Apnea Device Market is estimated to witness a CAGR of 7.6% during the forecast period 2017–2023. The Global Sleep Apnea Devices market is analyzed based on three segments, namely device types, end-users, and regions.
Regional Analysis Geographically, North America dominated the Global Sleep Apnea Devices Market followed by Europe. These two regions collectively occupy more than 60% of the total market. This was due to the availability of technologically advanced sleep laboratories and the increasing awareness of sleep apnea in these regions. Moreover, high obesity rate and good reimbursement facilities are accelerating the growth of the market. Asia Pacific and RoW are expected to have the highest growth rates during the forecast period. In addition, low awareness of the condition and lack of advanced technology products challenge the Global Sleep Apnea Devices Market growth.
Device Types Analysis: The diagnosis of sleep apnea is carried out by polysomnography (PSG), home sleep titration, and CPAP titration. The major share of the Global Sleep Apnea Devices Market is occupied by PSG diagnosis, which occupies more than half of the total market. However, the actigraphy devices are the fastest growing devices due to their high sensitivity during the sleep study process.
Post diagnosis, based on the severity, the patient is suggested to use therapeutic devices such as positive airway pressure (PAP) devices or oral appliances. The use of PAP device is the first-line therapy provided, and it occupies nearly half of the market. But nasal obstruction and discomfort of the CPAP masks, and nose and mouth dryness are some of the unmet needs of sleep apnea. Oral appliances are used to address the unmet need of the CPAP devices.
End-users Analysis: Among the end-users, a large portion of the market is occupied by hospitals and homecare. Technological advancements in the devices are giving rise to user-friendly and compact products. These factors are making the market for home sleep study products to grow at a high rate.
Key Players: The market leaders for sleep apnea devices are ResMed, Philips Healthcare, Becton Dickinson and Company (CareFusion), and Fisher and Paykel. Other leading players in the market include SomnoMed, Compumedics, Cadwell Laboratories, Imthera Medical, Itamar Medical, and BMC Medical.
Competitive Analysis: Currently, the CPAP devices and consumables are dominating the Global Sleep Apnea Devices market, but a lot of new players are focusing on developing next-generation diagnostic and therapeutic devices to gain future business opportunities. The market is dominated by ResMed, Fisher & Paykel, and Philips Healthcare. Small companies are investing greatly in developing technologically advanced products to gain their market share. In July 2017, Respicardia Inc., raised around $5.1 million for a pivotal trial of its implantable, pacemaker-like device for the treatment of sleep apnea.
Benefits: The report provides complete details about the usage and adoption rate of sleep apnea devices in various verticals and regions. Thus, the key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Sleep apnea is a condition in which a person stops breathing for few seconds at night either due to airway blockage or because signal from the brain is not received. In severe conditions, a person stops breathing for more than 10 times in an hour. The American Journal of Epidemiology stated that in 2013, around 26% of the adults aged 30–70 years had some form of sleep apnea, whereby 16% of them had mild sleep apnea and 10% had severe sleep apnea.
Among the various forms of sleep apnea, obstructive sleep apnea (OSA) is the most common type. According to the WHO around 100 million people worldwide have OSA. In the US, OSA is said to affect 1 in 4 men and 1 in 9 women, which totals to 23 million working adults. Center for Disease Control and Prevention has also found that the annual healthcare cost for OSA in the US is $165 billion, which is higher than asthma and obesity. Sleep apnea is resulting in reduced productivity at work and increase in road accidents. The National Highway Traffic Safety Administration has estimated that around 100,000 car accidents, 40,000 injuries, and 1,550 deaths per year are caused due to driver’s fatigue.
The Global Sleep Apnea Devices Market is growing due to factors such as the rising usage of oral appliances, growing awareness of ill effects of untreated sleep apnea in developed countries, technological advances in diagnostics and therapeutic devices, and the increasing number of lifestyle diseases such as diabetes and obesity. However, alternative treatment for sleep apnea, lack of patient compliance, and stringent regulatory approval are some of the factors hampering the market. The market in India, Brazil, and China are also expected to grow at an accelerated pace during the forecast period.
Market Analysis: The Global Sleep Apnea Device Market is estimated to witness a CAGR of 7.6% during the forecast period 2017–2023. The Global Sleep Apnea Devices market is analyzed based on three segments, namely device types, end-users, and regions.
Regional Analysis Geographically, North America dominated the Global Sleep Apnea Devices Market followed by Europe. These two regions collectively occupy more than 60% of the total market. This was due to the availability of technologically advanced sleep laboratories and the increasing awareness of sleep apnea in these regions. Moreover, high obesity rate and good reimbursement facilities are accelerating the growth of the market. Asia Pacific and RoW are expected to have the highest growth rates during the forecast period. In addition, low awareness of the condition and lack of advanced technology products challenge the Global Sleep Apnea Devices Market growth.
Device Types Analysis: The diagnosis of sleep apnea is carried out by polysomnography (PSG), home sleep titration, and CPAP titration. The major share of the Global Sleep Apnea Devices Market is occupied by PSG diagnosis, which occupies more than half of the total market. However, the actigraphy devices are the fastest growing devices due to their high sensitivity during the sleep study process.
Post diagnosis, based on the severity, the patient is suggested to use therapeutic devices such as positive airway pressure (PAP) devices or oral appliances. The use of PAP device is the first-line therapy provided, and it occupies nearly half of the market. But nasal obstruction and discomfort of the CPAP masks, and nose and mouth dryness are some of the unmet needs of sleep apnea. Oral appliances are used to address the unmet need of the CPAP devices.
End-users Analysis: Among the end-users, a large portion of the market is occupied by hospitals and homecare. Technological advancements in the devices are giving rise to user-friendly and compact products. These factors are making the market for home sleep study products to grow at a high rate.
Key Players: The market leaders for sleep apnea devices are ResMed, Philips Healthcare, Becton Dickinson and Company (CareFusion), and Fisher and Paykel. Other leading players in the market include SomnoMed, Compumedics, Cadwell Laboratories, Imthera Medical, Itamar Medical, and BMC Medical.
Competitive Analysis: Currently, the CPAP devices and consumables are dominating the Global Sleep Apnea Devices market, but a lot of new players are focusing on developing next-generation diagnostic and therapeutic devices to gain future business opportunities. The market is dominated by ResMed, Fisher & Paykel, and Philips Healthcare. Small companies are investing greatly in developing technologically advanced products to gain their market share. In July 2017, Respicardia Inc., raised around $5.1 million for a pivotal trial of its implantable, pacemaker-like device for the treatment of sleep apnea.
Benefits: The report provides complete details about the usage and adoption rate of sleep apnea devices in various verticals and regions. Thus, the key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Chronic Obstructive Pulmonary Disease
3.3.2 Anesthesia
3.3.3 Pulmonary Medicine
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Evolution
4.3 Types of Sleep Apnea
4.4 Symptoms of Sleep Apnea
4.5 Technologically Advanced Products
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Effects of Untreated Sleep Apnea
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising usage of oral appliances
5.2.1.2 Growing awareness of ill effects of untreated sleep apnea in developed countries
5.2.1.3 Technological advances in diagnostics and therapeutic devices
5.2.2 Opportunities
5.2.2.1 Huge pool of undiagnosed sleep apnea patients
5.2.2.2 Emerging markets in developing countries
5.2.3 Restraints
5.2.3.1 Stringent regulations for approval
5.2.3.2 Alternative treatment for sleep apnea
5.3 DRO – Impact Analysis
5.4 Key Stakeholders
6 PRODUCT: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Diagnostics Devices
6.2.1 Home Sleep Testing
6.2.2 CPAP Titration
6.2.3 Polysomnography (PSG) Devices
6.3 Therapeutic Devices
6.3.1 Oral Appliances
6.3.2 Positive Airway Pressure (PAP) Machines
6.3.3 PAP Consumables
7 END-USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals and Sleep Laboratories
7.3 Home Care
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Overview
8.2.2 US
8.2.3 Canada
8.3 Europe
8.3.1 Overview
8.3.2 UK
8.3.3 Germany
8.3.4 France
8.4 APAC
8.4.1 Overview
8.4.2 India
8.4.3 Japan
8.4.4 China
8.4.5 Australia
8.5 Rest of the World
8.5.1 Overview
8.5.2 Brazil
8.5.3 Middle East
8.5.4 Mexico
9 COMPETITIVE LANDSCAPE
10 VENDORS PROFILE
10.1 Becton Dickinson and Company
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 ResMed Inc.
10.2.1 Overview
10.2.2 Geographic Presence
10.2.3 Business Focus
10.2.4 SWOT Analysis
10.2.5 Business Strategies
10.3 Fisher & Paykel Healthcare Ltd.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Philips Healthcare
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Cadwell Laboratories
11.1.1 Overview
11.2 Somnomed Ltd.
11.2.1 Overview
11.3 Compumedics Ltd.
11.3.1 Overview
11.4 Itamar Medical Ltd.
11.4.1 Overview
11.5 BMC Medical Co Ltd.
11.5.1 Overview
11.6 ImThera Medical
11.6.1 Overview
Annexure
Abbreviations
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Chronic Obstructive Pulmonary Disease
3.3.2 Anesthesia
3.3.3 Pulmonary Medicine
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Evolution
4.3 Types of Sleep Apnea
4.4 Symptoms of Sleep Apnea
4.5 Technologically Advanced Products
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Effects of Untreated Sleep Apnea
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising usage of oral appliances
5.2.1.2 Growing awareness of ill effects of untreated sleep apnea in developed countries
5.2.1.3 Technological advances in diagnostics and therapeutic devices
5.2.2 Opportunities
5.2.2.1 Huge pool of undiagnosed sleep apnea patients
5.2.2.2 Emerging markets in developing countries
5.2.3 Restraints
5.2.3.1 Stringent regulations for approval
5.2.3.2 Alternative treatment for sleep apnea
5.3 DRO – Impact Analysis
5.4 Key Stakeholders
6 PRODUCT: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Diagnostics Devices
6.2.1 Home Sleep Testing
6.2.2 CPAP Titration
6.2.3 Polysomnography (PSG) Devices
6.3 Therapeutic Devices
6.3.1 Oral Appliances
6.3.2 Positive Airway Pressure (PAP) Machines
6.3.3 PAP Consumables
7 END-USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals and Sleep Laboratories
7.3 Home Care
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Overview
8.2.2 US
8.2.3 Canada
8.3 Europe
8.3.1 Overview
8.3.2 UK
8.3.3 Germany
8.3.4 France
8.4 APAC
8.4.1 Overview
8.4.2 India
8.4.3 Japan
8.4.4 China
8.4.5 Australia
8.5 Rest of the World
8.5.1 Overview
8.5.2 Brazil
8.5.3 Middle East
8.5.4 Mexico
9 COMPETITIVE LANDSCAPE
10 VENDORS PROFILE
10.1 Becton Dickinson and Company
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 ResMed Inc.
10.2.1 Overview
10.2.2 Geographic Presence
10.2.3 Business Focus
10.2.4 SWOT Analysis
10.2.5 Business Strategies
10.3 Fisher & Paykel Healthcare Ltd.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Philips Healthcare
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Cadwell Laboratories
11.1.1 Overview
11.2 Somnomed Ltd.
11.2.1 Overview
11.3 Compumedics Ltd.
11.3.1 Overview
11.4 Itamar Medical Ltd.
11.4.1 Overview
11.5 BMC Medical Co Ltd.
11.5.1 Overview
11.6 ImThera Medical
11.6.1 Overview
Annexure
Abbreviations
LIST OF TABLES
Table 1 SLEEP APNEA DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
Table 2 HOME SLEEP TESTING DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
Table 3 SLEEP APNEA PREVALENCE RATE
Table 4 SLEEP APNEA DEVICES MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 5 OTHER PROMINENT VENDORS IN THE SLEEP APNEA DEVICES MARKET
Table 6 BECTON DICKINSON AND COMPANY: OFFERINGS
Table 7 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS
Table 8 RESMED INC.: OFFERINGS
Table 9 RESMED INC.: RECENT DEVELOPMENTS
Table 10 FISHER & PAYKEL HEALTHCARE LTD.: OFFERINGS
Table 11 FISHER & PAYKEL HEALTHCARE LTD.: RECENT DEVELOPMENTS
Table 12 PHILIPS HEALTHCARE: OFFERINGS
Table 13 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS
Table 14 CADWELL LABORATORIES, INC.: RECENT DEVELOPMENTS
Table 15 SOMNOMED LTD.: RECENT DEVELOPMENTS
Table 16 COMPUMEDICS LTD.: RECENT DEVELOPMENTS
Table 17 ITAMAR MEDICAL LTD.: RECENT DEVELOPMENTS
Table 18 BMC MEDICAL: RECENT DEVELOPMENTS
Table 19 IMTHERA MEDICAL: HIGHLIGHTS
Table 1 SLEEP APNEA DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
Table 2 HOME SLEEP TESTING DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
Table 3 SLEEP APNEA PREVALENCE RATE
Table 4 SLEEP APNEA DEVICES MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 5 OTHER PROMINENT VENDORS IN THE SLEEP APNEA DEVICES MARKET
Table 6 BECTON DICKINSON AND COMPANY: OFFERINGS
Table 7 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS
Table 8 RESMED INC.: OFFERINGS
Table 9 RESMED INC.: RECENT DEVELOPMENTS
Table 10 FISHER & PAYKEL HEALTHCARE LTD.: OFFERINGS
Table 11 FISHER & PAYKEL HEALTHCARE LTD.: RECENT DEVELOPMENTS
Table 12 PHILIPS HEALTHCARE: OFFERINGS
Table 13 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS
Table 14 CADWELL LABORATORIES, INC.: RECENT DEVELOPMENTS
Table 15 SOMNOMED LTD.: RECENT DEVELOPMENTS
Table 16 COMPUMEDICS LTD.: RECENT DEVELOPMENTS
Table 17 ITAMAR MEDICAL LTD.: RECENT DEVELOPMENTS
Table 18 BMC MEDICAL: RECENT DEVELOPMENTS
Table 19 IMTHERA MEDICAL: HIGHLIGHTS
LIST OF CHARTS
Chart 1 PEST ANALYSIS OF SLEEP APNEA DEVICES MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 3 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 4 SEGMENTATION OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 5 PORTER 5 FORCES OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 6 MARKET DYNAMICS – DRO ANALYSIS
Chart 7 DRO – IMPACT ANALYSIS OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 8 KEY STAKEHOLDERS
Chart 9 SLEEP APNEA DEVICES MARKET SEGMENT SHARE, 2016 VS 2023 (%)
Chart 10 DIAGNOSTIC SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 11 DIAGNOSTIC SLEEP APNEA DEVICES MARKET SHARE BY TYPE, 2016 (%)
Chart 12 THERAPEUTIC SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 13 THERAPEUTIC SLEEP APNEA DEVICES MARKET SHARE BY TYPE, 2016 (%)
Chart 14 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER SEGMENTATION, 2016 VS 2023 (%)
Chart 15 GLOBAL SLEEP APNEA DEVICES MARKET BY REGIONAL SEGMENTATION, 2016 VS 2023 (%)
Chart 16 SLEEP APNEA DEVICES MARKET REVENUE IN NORTH AMERICA, 2017–2023 ($MILLION)
Chart 17 SLEEP APNEA DEVICES MARKET REVENUE IN THE EUROPE REGION, 2017–2023 ($MILLION)
Chart 18 SLEEP APNEA DEVICES MARKET REVENUE IN THE APAC REGION, 2017–2023 ($MILLION)
Chart 19 SLEEP APNEA DEVICES MARKET REVENUE IN REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 20 BECTON DICKINSON AND COMPANY: OVERVIEW SNAPSHOT
Chart 21 BECTON DICKINSON AND COMPANY: BUSINESS UNITS
Chart 22 BECTON DICKINSON AND COMPANY: GEOGRAPHIC PRESENCE
Chart 23 BECTON DICKINSON AND COMPANY: SWOT ANALYSIS
Chart 24 RESMED INC.: OVERVIEW SNAPSHOT
Chart 25 RESMED INC.: GEOGRAPHIC PRESENCE
Chart 26 RESMED INC.: SWOT ANALYSIS
Chart 27 FISHER & PAYKEL HEALTHCARE LTD.: OVERVIEW SNAPSHOT
Chart 28 FISHER & PAYKEL HEALTHCARE LTD.: BUSINESS UNITS
Chart 29 FISHER & PAYKEL HEALTHCARE LTD.: GEOGRAPHIC PRESENCE
Chart 30 FISHER & PAYKEL HEALTHCARE LTD.: SWOT ANALYSIS
Chart 31 PHILIPS HEALTHCARE: OVERVIEW SNAPSHOT
Chart 32 PHILIPS HEALTHCARE: BUSINESS UNITS
Chart 33 PHILIPS HEALTHCARE: GEOGRAPHIC PRESENCE
Chart 34 PHILIPS HEALTHCARE: SWOT ANALYSIS
Chart 1 PEST ANALYSIS OF SLEEP APNEA DEVICES MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 3 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 4 SEGMENTATION OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 5 PORTER 5 FORCES OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 6 MARKET DYNAMICS – DRO ANALYSIS
Chart 7 DRO – IMPACT ANALYSIS OF GLOBAL SLEEP APNEA DEVICES MARKET
Chart 8 KEY STAKEHOLDERS
Chart 9 SLEEP APNEA DEVICES MARKET SEGMENT SHARE, 2016 VS 2023 (%)
Chart 10 DIAGNOSTIC SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 11 DIAGNOSTIC SLEEP APNEA DEVICES MARKET SHARE BY TYPE, 2016 (%)
Chart 12 THERAPEUTIC SLEEP APNEA DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 13 THERAPEUTIC SLEEP APNEA DEVICES MARKET SHARE BY TYPE, 2016 (%)
Chart 14 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER SEGMENTATION, 2016 VS 2023 (%)
Chart 15 GLOBAL SLEEP APNEA DEVICES MARKET BY REGIONAL SEGMENTATION, 2016 VS 2023 (%)
Chart 16 SLEEP APNEA DEVICES MARKET REVENUE IN NORTH AMERICA, 2017–2023 ($MILLION)
Chart 17 SLEEP APNEA DEVICES MARKET REVENUE IN THE EUROPE REGION, 2017–2023 ($MILLION)
Chart 18 SLEEP APNEA DEVICES MARKET REVENUE IN THE APAC REGION, 2017–2023 ($MILLION)
Chart 19 SLEEP APNEA DEVICES MARKET REVENUE IN REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 20 BECTON DICKINSON AND COMPANY: OVERVIEW SNAPSHOT
Chart 21 BECTON DICKINSON AND COMPANY: BUSINESS UNITS
Chart 22 BECTON DICKINSON AND COMPANY: GEOGRAPHIC PRESENCE
Chart 23 BECTON DICKINSON AND COMPANY: SWOT ANALYSIS
Chart 24 RESMED INC.: OVERVIEW SNAPSHOT
Chart 25 RESMED INC.: GEOGRAPHIC PRESENCE
Chart 26 RESMED INC.: SWOT ANALYSIS
Chart 27 FISHER & PAYKEL HEALTHCARE LTD.: OVERVIEW SNAPSHOT
Chart 28 FISHER & PAYKEL HEALTHCARE LTD.: BUSINESS UNITS
Chart 29 FISHER & PAYKEL HEALTHCARE LTD.: GEOGRAPHIC PRESENCE
Chart 30 FISHER & PAYKEL HEALTHCARE LTD.: SWOT ANALYSIS
Chart 31 PHILIPS HEALTHCARE: OVERVIEW SNAPSHOT
Chart 32 PHILIPS HEALTHCARE: BUSINESS UNITS
Chart 33 PHILIPS HEALTHCARE: GEOGRAPHIC PRESENCE
Chart 34 PHILIPS HEALTHCARE: SWOT ANALYSIS
